MERIDIA
LOE ApproachingNDAORALCAPSULE
Approved
Nov 1997
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Clinical Trials
4
Data completeness
2/8 — Basic
Drug data last refreshed 6d ago · AI intelligence enriched 3w ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
MERIDIA is an oral capsule approved in 1997 for pelvic inflammatory disease, chronic pelvic pain, biliary colic, and jet lag disorder. The mechanism of action and pharmacologic class are unknown. It is a small-molecule NDA product manufactured by Abbott.
LOE Approaching
As LOE approaches, the brand team is likely in transition mode with focus shifting toward lifecycle extension or managed decline strategies rather than growth initiatives.
Mechanism of Action
Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Clinical Trials (4)
MERIDIAN: A Study to Evaluate the Efficacy and Safety of Pegcetacoplan in Adults With Amyotrophic Lateral Sclerosis (ALS)
Started Sep 2020
249 enrolled
Amyotrophic Lateral SclerosisMotor Neuron Disease
An Observational Study to Investigate the Effects of Rapid Transmeridian Travel
Started Sep 2015
119 enrolled
Jet Lag Disorder
Efficacy and Safety of Dianicline Treatment as an Aid to Smoking Cessation in Cigarette Smokers (AMERIDIAN)
Started Sep 2006
630 enrolled
Smoking CessationTobacco Use Cessation
A Study to Examine the Efficacy and Safety of Meridia® (Sibutramine Hydrochloride) in Binge-Eating Disorder
Started Aug 2000
304 enrolled
Binge Eating DisorderObesity
Worked on MERIDIA at Abbott? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.